Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer - Concepedia

Concepedia

Publication | Closed Access

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

2.2K

Citations

21

References

2008

Year

Johann S. de Bono, Howard I. Scher, Bruce Montgomery, Christopher Parker, Michael Craig Miller, H. Tissing, Gerald V. Doyle, Leon W.M.M. Terstappen, Kenneth J. Pienta, Derek Raghavan

Clinical Cancer Research

Abstract

CTC are the most accurate and independent predictor of OS in CRPC. These data led to Food and Drug Administration clearance of this assay for the evaluation of CRPC.

References

	Year	Citations

Page 1